Organization
Brainvectis
1 clinical trial
Clinical trial
An Open-Label Phase I/II Dose Finding Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Striatal Administration of AB-1001 in Adult Subjects With Early Manifest Huntington's Disease (HD)Status: Active (not recruiting), Estimated PCD: 2025-12-31